🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

President Zelenskyy has been one of the greatest leaders of our time, leading Ukraine through the darkest period of its recent history, rising up to Russia’s aggression, being an inspiration to the Ukrainian people and ensuring that Ukraine’s voice is heard on the world stage.

We are witnessing a very sad moment in American history. The President of the United States is aligning himself with the dictator of Russia, Vladimir Putin, to undermine the independence of Ukraine and its democracy. Here are my thoughts:

Between 1000 and 2000AD, 10% of all humans deaths were caused by smallpox. But today, that figure is zero, thanks to compulsory smallpox vaccinations. So smallpox vaccines were 100% successful in preventing deaths.

BREAKING: Former Prime Minister of the UK, Boris Johnson, just completely went off on Trump’s idea that Ukraine is the aggressor and debunked all of the Russian propaganda that is being spread: “Putin launched his war not because he was worried about Nato – that's pure Kremlin

Zelensky cares more about Ukraine and Ukrainians, present and future, than about himself or what people say about him. This makes him incomprehensible to people like Trump and Musk, who care only about their personal power and image. He is a living rebuke.

Treatment Algorithm: This is the algorithm we’ve used during our 🗣️ w/ Kevin Kalinsky, MD, MS, FASCO for HR+ #BreastCancer! #OncTwitter #bcsm #MedTwitter CancerNetwork® OncoAlert

The “US-led order” died last week and was buried today when the land of the free voted in the UN to shield Russia from criticism over Ukraine. In the assembly the US voted with Russia, Belarus and North Korea.

A trio of radiation oncologists from France, the United States, and Australia asks why there is a desire to deliver SBRT to ultra-central tumors. Especially when a 3-week hypofractionation (60/15) course seems to be just fine. Shankar Siva sciencedirect.com/science/articl…

Superb talk by Professor Samreen Ahmed on ADC resistance. Reminds us that for DAR higher doesn’t mean more efficacy, that internalization and cleavability of linker is key to efficacy. Re ADC design: “Porridge for the bears, it has to be just right” Bravo! BTOG

New Lab photo

In the garden of the French Embassy in Washington DC. 🇫🇷✊🇺🇦

Interesting to still hear the complete fallacy that “walking is enough” and “just moving makes a difference” when thinking of exercise medicine for cancer. Sure, it helps. But it does nothing for muscle or bone health- two tissues with direct links to frailty and premature death.

Guiding Treatment for Patients With Prostate Cancer With Biochemical Recurrence After Prostatectomy dailynews.ascopubs.org/do/guiding-tre… with Amar Kishan Daniel E Spratt Thanks ASCO Daily News Related Nature Reviews Urology article: pubmed.ncbi.nlm.nih.gov/34363040/ x.com/NicholasZaorsk…

He died #OnThisDay 6 years ago, & #F1 & the #FIA still miss him every single day. #RIPCharlieWhiting

Research from our Exercise Medicine Research Institute and led by one of our PhD students Francesco Bettariga Francesco Bettariga was featured on the Channel9 News in Perth, Western Australia and produced by Edith Cowan University (ECU) graduate - Brooke Comerford Brooke Comerford. Strong evidence that

An excellent debate here in #ELCC25 on the optimal choice for 1st Line treatment of EGFR pos #NSCLC : ⭐️. Osimertinib monotherapy VS Combinations (FLAURA2/MARIPOSA) Insightful lectures by Zosia Piotrowska and Aɴᴛᴏɴɪᴏ Pᴀssᴀʀᴏ focusing on efficacy endpoints, biology, toxicity and

👉🏽Out in Journal of Clinical Oncology #Taletrectinib Next Gen TKI in ROS1+ Non–Small Cell Lung Cancer: #TRUST pooled analysis 🎯TKI-naïve/pretreated: ORR 88.8/55.8%, 🧠Intracranial-ORR 76.5/65.6%, mPFS 45.6/9.7mo ➡️AEs: LFT abnormalities, diarrhea, edema, less neuro AEs Maurice Perol Nathan A. Pennell MD, PhD, FASCO

👉 Two practice changing trials that will shape a new era in the treatment of patients with SCLC #ASCO25 #LCSM SmallCellSMASHERS

🚨 BREAKING | Press Release today DESTINY-Breast11 🧪 Neoadjuvant Enhertu ➕ THP showed ⭐ statistically significant & clinically meaningful improvement in pCR vs ddAC➕THP In high-risk ⚠️, locally advanced HER2+ 🧬 early breast cancer Early EFS trend 📈 also favored Enhertu!

Successfully identified spindle cells at tumor board and this must have been how Neo felt when he could see the Matrix